Last updated on November 2017

CONVERGE


Brief description of study

CONVERGE

Detailed Study Description

This study is evaluating 2 different treatment options for persistent atrial fibrillation. In this multi-center, pivotal clinical study, patients are randomized (2:1) to either a convergent procedure that includes both epicardial and endocardial atrial ablation versus standalone endocardial catheter ablation. The study will enroll and randomize one hundred and fifty three (153) patients from up to thirty (30) sites with twenty-seven (27) in the US and three (3) sites OUS.

Clinical Study Identifier: TX11446

Contact Investigators or Research Sites near you

Start Over

Jessica Marsh, RN

Heart Center Research LLC
Huntsville, AL USA

Shine Y. Kim, BSN, RN

MedStar Washington Hospital Center
Washington, DC USA

Cynthia Barnes, RN

Emory University - St. Joseph's Hospital
Atlanta, GA USA

Sara Simpkiss

St. Vincent Medical Group Inc.
Indianapolis, IN USA

Becky Toler, RN, BSN

Cardiovascular Research Foundation of Louisiana
Baton Rouge, LA USA

Jean Byrne, RN

Lahey Clinic
Burlington, MA USA

Sandra Watt, RN

Genesys Regional Medical Center
Grand Blanc, MI USA

Angela Long, RN

Cardiology Associates Research, LLC
Tupelo, MS USA

Melanee Tomasulo, RN BSN

Cary Research Group, LLC/Wake Medical Center
Raleigh, NC USA

KeriAnn Shuman, RN

Summa Health System
Akron, OH USA

Barbara Fortanely, RN, CCRP

Austin Heart PLLC
Austin, TX USA

DD Castillo

STAR Clinical Trials LLC
San Antonio, TX USA

Laura Puckett, RN

Virginia Cardiovascular Specialists
Richmond, VA USA